Torqueability, Pushability, Steerability Key Words For Boston Sci’s New Victory™ PAD Guidewire

In short

Peripheral vascular treatment has been creeping into our pages in the past few months with more and more companies venturing into the developing specialism of Peripheral Artery Disease. Now Boston Scientific Corporation has announced the U.S. and European launch of its Victory™ guidewire, designed to facilitate crossing of resistant lesions and the placement and exchange of balloon catheters or other interventional devices within the peripheral vasculature.

Background

In a press release, Boston Scientific points to 17.6 million Americans suffering from peripheral artery disease, which is characterised by blockage or narrowing in vessels of the peripheral vasculature, and which is frequently associated with high rates of morbidity and mortality. Resultant critical limb ischemia (CLI), if left untreated, can lead to limb loss. Indeed an estimated 25 percent of U.S. patients with peripheral artery disease will require amputation within one year of onset of CLI. So the scene is set for the endovascular PAD intervention, because it’s clear that saving limbs, whether through surgery or endovascular techniques improves the quality of life for patients.

Boston Scientific’s Victory guidewires are designed to address one of the bigger challenges for the physician, the so-called cross-resistant lesion. The wires feature a broad matrix of high gram-load tip options ranging from 12g to 30g and a unique stainless steel core technology, which confers what the company refers to as “superior torque for optimal steering and control”.

A hydrophilic coating provides enhanced lubricity to further facilitate crossing resistant lesions.

The Victory guidewires come in both 0.014″ and 0.018″ diameters with four different gram-load options offering clinical versatility and a range of pushability.

Physician comments

“Resistant lesions can be a challenge and I often need various tools to access, cross and treat these types of lesions,” said Derek Mittleider , M.D., Interventional Radiologist, Director, Vascular and Interventional Radiology, Spectrum Medical Group. “The Victory wire’s high gram-load options and excellent torque-ability give me the extra push and steer-ability I need to get through these resistant lesions more easily, making these cases less challenging.”

Company comments

“Physicians treating CLI patients typically require a variety of treatment options. Boston Scientific is committed to offering a wide variety of crossing solutions,” said Jeff Mirviss , president of the Boston Scientific Peripheral Interventions Division. “Victory guidewires complement our already broad portfolio of crossing solutions, inclusive of our market-leading angioplasty balloons, Rubicon™ Support Catheter and the TruePath™ CTO device. The Victory guidewires offer another option to cross these highly resistant lesions and potentially avoid the need for amputation.”

Source: Boston Scientific Corp., PR Newswire